FDA.reportPublic FDA data

Evenity 105 MG per 1.17 ML Prefilled Syringe

RxCUI
2123190
RxNorm name
Evenity 105 MG per 1.17 ML Prefilled Syringe
Display name
Evenity 105 MG per 1.17 ML Prefilled Syringe
Full name
Evenity 105 MG per 1.17 ML Prefilled Syringe
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:56

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761062Evenityromosozumab-aqqg351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EvenityROMOSOZUMAB-AQQGAmgen, Inc471baba2-7154-4488-9891-0db2f46791e72026-07-16Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2123190

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
471baba2-7154-4488-9891-0db2f46791e7Evenity 105 MG per 1.17 ML Prefilled SyringeSY17These highlights do not include all the information needed to use EVENITY safely and effectively. See full prescribing information for EVENITY. EVENITY ® (romosozumab-aqqg) injection, for subcutaneous use Initial U.S. Approval: 201920260108
471baba2-7154-4488-9891-0db2f46791e71.17 ML Evenity 89.7 MG/ML Prefilled SyringeSY17These highlights do not include all the information needed to use EVENITY safely and effectively. See full prescribing information for EVENITY. EVENITY ® (romosozumab-aqqg) injection, for subcutaneous use Initial U.S. Approval: 201920260108
471baba2-7154-4488-9891-0db2f46791e71.17 ML romosozumab-aqqg 89.7 MG/ML Prefilled Syringe [Evenity]SBD17These highlights do not include all the information needed to use EVENITY safely and effectively. See full prescribing information for EVENITY. EVENITY ® (romosozumab-aqqg) injection, for subcutaneous use Initial U.S. Approval: 201920260108
471baba2-7154-4488-9891-0db2f46791e7Evenity 105 MG in 1.17 mL Prefilled SyringePSN17These highlights do not include all the information needed to use EVENITY safely and effectively. See full prescribing information for EVENITY. EVENITY ® (romosozumab-aqqg) injection, for subcutaneous use Initial U.S. Approval: 201920260108